On Thursday, Whole Foods Market, Inc. (NASDAQ:WFM)’s shares declined -0.38% to $40.58.
Whole Foods Market, Inc. (WFM) is now the first major national grocery retailer in America to use the new, natural and sustainable choice in receipt paper that shoppers can feel good about at checkout.
A naturally occurring yellow tint assists Alpha Free stand out in a crowd and lets shoppers know what is (and isn’t!) in their receipt.
In addition to its unique formulation and yellow color, Alpha Free receipts are:
- 100 percent recyclable
- Compostable in most areas
- Made in the United States
With more shoppers than ever focused on green living and healthy options, switching to vitamin C-formulated Alpha Free receipts was an easy decision for Whole Foods.
Whole Foods Market is the first major grocery store chain to offer receipt paper free of controversial chemicals in both their Rocky Mountain and Southern California regions. Appvion’s partnership with Whole Foods Market supports Whole Foods Market’s dedication to providing naturally occurring and sustainable products as they start to cut down on waste while raising standards for employee and customer health.
Whole Foods Market, Inc. operates as a retailer of natural and organic foods. The company’s stores offer produce and floral, grocery, meat, seafood, bakery, prepared foods and catering, coffee, tea, beer, wine, cheese, nutritional supplements, vitamins, and body care products, in addition to lifestyle products, counting books, pet products, and household products. As of May 7, 2015, the company had about 417 stores worldwide.
ONEOK, Inc. (NYSE:OKE)’s shares gained 0.15% to $39.38.
ONEOK, Inc. (OKE) the company declared and paid three dividends, and in January 2015, raised the dividend 7 percent.
Shareholders approved the following proposals:
- Election of three directors to the ONE Gas Board of Directors each for a three-year term;
- Selection of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2015;
- Performance aims and approval of the company’s executive compensation plan on an advisory basis; and
- Advisory votes on executive compensation will be conducted on a yearly basis.
ONE Gas trades on the New York Stock Exchange under the symbol “OGS,” and is comprised of in the S&P MidCap 400 Index.
ONE Gas provides natural gas distribution services to more than 2 million customers in Oklahoma, Kansas and Texas. ONE Gas is one of the largest publicly traded, 100 percent regulated, natural gas utilities in the United States.
ONE Gas, Inc. (OGS) is a natural gas distribution company and the successor to the company founded in 1906 as Oklahoma Natural Gas Company, which became ONEOK, Inc. (OKE) in 1980. On January 31, 2014, ONE Gas officially separated from ONEOK into a stand-alone, 100 percent regulated, publicly traded natural gas utility.
ONE Gas is headquartered in Tulsa, Okla., and its companies comprise the largest natural gas distributor in Oklahoma and Kansas, and the third largest in Texas, in terms of customers.
ONEOK, Inc. engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates in Natural Gas Gathering and Processing, Natural Gas Liquids, and Natural Gas Pipelines segments.
At the end of Thursday’s trade, Celgene Corporation (NASDAQ:CELG)‘s shares surged 0.81% to $112.97.
Celgene International Sàrl, a wholly-owned partner of Celgene Corporation (CELG), declared that the findings from a long-term (104-week) post-hoc analysis of pooled data from the PALACE phase III clinical trial program of Otezla® (apremilast) will be presented at the European League Against Rheumatism (EULAR) Annual Congress in Rome, Italy. OTEZLA is the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4) approved for the treatment of adults with active psoriatic arthritis.
The study abstract states that treatment with OTEZLA 30 mg twice daily in patients with pre-existing enthesitis (inflammation at sites where tendons or ligaments insert into bone) or dactylitis (inflammation of an entire digit) — two distinct manifestations of psoriatic arthritis — demonstrated improvements in these symptoms at 52 weeks and that improvements were sustained through week 104. For patients taking OTEZLA 30 mg twice daily, the mean Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) was reduced by 43.5 percent at week 52 (n=377) and by 57.5 percent at week 104 (n=302). A score of 0, indicating no pain at any of the sites assessed, was achieved by 37.7 percent of patients at week 52 and 48.7 percent at week 104.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
Avago Technologies Ltd (NASDAQ:AVGO), ended its Thursday’s trading session with -0.61% loss, and closed at $141.99.
Avago Technologies Ltd (AVGO) declared that its Board of Directors has approved a quarterly, interim cash dividend of $0.40 per ordinary share.
The dividend is payable on June 30, 2015 to shareholders of record at the close of business (5:00 p.m.) Eastern Time on June 19, 2015.
Avago Technologies Limited designs, develops, and supplies semiconductor devices with a focus on analog III-V based products. The company operates through four segments: Wireless Communications, Wired Infrastructure, Enterprise Storage, and Industrial & Other segments. Its product portfolio comprises RF power amplifiers, RF filters, RF front end modules, ambient light sensors, proximity sensors, low noise amplifiers, multimarket-wave mixers, diodes, fiber optic transceivers, serializer/deserializer ASICs, and optical laser and receiver components.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
